MedTrace Logo

Genomic Analysis of Pediatric Bone Tumors

NCT01047878 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 163

Last updated 2020-07-28

No results posted yet for this study

Summary

To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).

Conditions

  • Bone Cancer

Sponsors & Collaborators

Principal Investigators

  • Arun A Rangaswami · Stanford University

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2018-06-30
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01047878 on ClinicalTrials.gov